Insider · CIK 0001643085
Steven Gannon
Files at XENE (Xenon Pharmaceuticals Inc.). First filing Jun 6, 2025, latest Jun 6, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
XENE: Xenon Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | XENEsell Xenon Pharmaceuticals Inc. | $91 3 shares | -0% | +9% from low-33% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | SOpen-market sale Common Shares | -3 | $30.48 | $91 | 7,141 | Jun 6, 2025 |
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | AGrant or award Share Option (Right to Buy)derivative | +17,012 | $0.00 | $0 | 17,012 | Jun 6, 2025 |
| Jun 5, 2025 | XENE Xenon Pharmaceuticals Inc. | AGrant or award Restricted Share Unitsderivative | +2,645 | $0.00 | $0 | 2,645 | Jun 6, 2025 |
| May 14, 2025 | XENE Xenon Pharmaceuticals Inc. | MOption exercise Common Shares | +5,144 | $12.57 | $65k | 7,144 | May 16, 2025 |
| May 14, 2025 | XENE Xenon Pharmaceuticals Inc. | MOption exercise Stock Option (Right to Buy)derivative | -5,144 | $0.00 | $0 | 0 | May 16, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.